Gå direkt till innehåll
Visual_OYSTA launch_25.10.2022

Bild -

Visual_OYSTA launch_25.10.2022

go to media item
Licens:
All rights reserved
Innehållet får bara användas av Mynewsdesk. Det är alltså inte tillåtet för någon annan att ladda ner, kopiera, sprida eller på annat sätt använda Innehållet (annat än för privat bruk i den mån det följer av lag).
Filformat:
.png
Storlek:
4724 x 3543, 854 KB

Ämnen

Kontakter

Martin Olovsson

Martin Olovsson

Presskontakt CEO Ondosis +46 76-772 85 01

Relaterat innehåll

TIEFENBACHER GROUP and OnDosis launch the innovative healthcare brand OYSTA®

TIEFENBACHER GROUP and OnDosis launch the innovative healthcare brand OYSTA®

TIEFENBACHER GROUP and OnDosis are thrilled to announce the launch of OYSTA®. The new healthcare brand represents the cooperation initiated in September 2020, including the co-development portfolio of innovative products in five indications. OYSTA® aims to revolutionize the way how patients take their medicines by combining pharmaceuticals with e-health technology to enable intuitive, precise, and

OnDosis – Changing the game, one dose at a time

Founded as a spin-out from AstraZeneca in 2017, OnDosis is a Swedish start-up addressing one of the major opportunities in healthcare; personalized dosage of medicines. The proprietary technology platform is centered around a connected handheld dosing device that delivers tailored doses of oral medicines. By combining individual dosing of traditional drug-based medicines augmented by digital therapeutics, OnDosis opens a new chapter in personalized medicine where the mission is to improve patients’ life through delivering the perfect dosage; individualized, intuitive, and intelligent.

OnDosis AB

Pepparedsleden 1
431 50 Mölndal
Sweden